MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. [electronic resource]
Producer: 20130311Description: 340-7 p. digitalISSN:- 1558-8238
- Animals
- Benzamides -- pharmacology
- Child
- Child, Preschool
- Diphenylamine -- analogs & derivatives
- Extracellular Signal-Regulated MAP Kinases -- genetics
- Female
- Humans
- Male
- Mice
- Mice, Mutant Strains
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Neoplasm Transplantation
- Neurofibromatosis 1 -- drug therapy
- Oncogene Protein p21(ras) -- genetics
- Peripheral Nervous System Neoplasms -- drug therapy
- Transcriptome -- drug effects
- Transplantation, Heterologous
- Xenograft Model Antitumor Assays
- raf Kinases -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.